Injectable calcium hydroxylapatite microspheres (Radiesse).
Injectable calcium hydroxylapatite (Radiesse) received FDA approval in 2006 for the correction of facial lipoatrophy and moderate to severe facial wrinkles. This product consists of microspheres of a synthetic bone suspended in a methylcellulose gel matrix. Because the product is thicker than the hyaluronic acids, it is used for the correction of moderate to severe wrinkles, such as deep nasolabial folds. It is also used "off-label" to treat multiple areas of the face, nose, and hands. Radiesse is injected into the subdermal plane, and correction lasts approximately 1 year after injection.
Ridenour
Brock
B
Ridenour Plastic Surgery, St. Louis, Missouri 63141, USA. Brock.ridenour@ridenourplasticsurgery.com
Kontis
Theda C
TC
D001672:Biocompatible Materials / Q000008:administration & dosage* / Q000009:adverse effects; D003094:Collagen / Q000008:administration & dosage; D003357:Cosmetic Techniques; D017886:Durapatite / Q000008:administration & dosage* / Q000009:adverse effects; D005145:Face; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D008060:Lipodystrophy / Q000188:drug therapy; D008863:Microspheres; D015361:Rhytidoplasty / Q000379:methods; D015595:Skin Aging
D001672:Biocompatible Materials; D006820:Hyaluronic Acid; D003094:Collagen; D017886:Durapatite